Description: Danaher will buy the biopharmaceutical business of General Electricin a $21.4 billion deal, the companies announced Monday.
Source: CNBC.com – video report
Date: Feb 25, 2019
Questions for discussion:
- What motivated the deal for each firm?
- Explain the rise in stock values?
- Is this deal good for GE investors in the long run?